References
- O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 2000;13:534-546. https://doi.org/10.1128/CMR.13.4.534-546.2000
- Warren JW. Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters. Rev Infect Dis 1986;8:61-67. https://doi.org/10.1093/clinids/8.1.61
- Prentice B, Robinson BL. A review of Providencia bacteremia in a general hospital, with a comment on patterns of antimicrobial sensitivity and use. Can Med Assoc J 1979;121:745-749.
- Woods TD, Watanakunakorn C. Bacteremia due to Providencia stuartii: review of 49 episodes. South Med J 1996;89:221-224. https://doi.org/10.1097/00007611-199602000-00013
- Kim BN, Kim NJ, Kim MN, Kim YS, Woo JH, Ryu J. Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000). Scand J Infect Dis 2003;35:98-103. https://doi.org/10.1080/0036554021000027015
- Stickler DJ. Susceptibility of antibiotic-resistant gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. Symp Ser Soc Appl Microbiol 2002:163S-170S.
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 19th Informational Supplement. CLSI Document M100-S19. Wayne: Clinical and Laboratory Standards Institute, 2009.
- Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-1655. https://doi.org/10.1378/chest.101.6.1644
- McCabe WR, Jackson GG. Gram-negative bacteremia: II. clinical, laboratory, and therapeutic observations. Arch Intern Med 1962;110:856-864. https://doi.org/10.1001/archinte.1962.03620240038007
- Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999;11:7-12. https://doi.org/10.1016/S0924-8579(98)00060-0
- Shima A, Hinenoya A, Asakura M, et al. Molecular characterizations of cytolethal distending toxin produced by Providencia alcalifaciens strains isolated from patients with diarrhea. Infect Immun 2012;80:1323-1332. https://doi.org/10.1128/IAI.05831-11
- Albert MJ, Alam K, Ansaruzzaman M, et al. Pathogenesis of Providencia alcalifaciens-induced diarrhea. Infect Immun 1992;60:5017-5024.
- Yoh M, Matsuyama J, Ohnishi M, et al. Importance of Providencia species as a major cause of travellers' diarrhoea. J Med Microbiol 2005;54(Pt 11):1077-1082. https://doi.org/10.1099/jmm.0.45846-0
- Kang CI, Song JH, Chung DR, et al. Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. J Infect 2011;62:26-33. https://doi.org/10.1016/j.jinf.2010.10.010
- Gikas A, Samonis G, Christidou A, et al. Gram-negative bacteremia in non-neutropenic patients: a 3-year review. Infection 1998;26:155-159. https://doi.org/10.1007/BF02771841
- Tumbarello M, Citton R, Spanu T, et al. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. J Antimicrob Chemother 2004;53:277-282. https://doi.org/10.1093/jac/dkh047
- Rose WE, Rybak MJ. Tigecycline: first of a new class of antimicrobial agents. Pharmacotherapy 2006;26:1099-1110. https://doi.org/10.1592/phco.26.8.1099
- Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 2005;25:11-25. https://doi.org/10.1016/j.ijantimicag.2004.10.001
- Fass RJ, Barnishan J, Ayers LW. Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital. J Antimicrob Chemother 1995;36:343-353. https://doi.org/10.1093/jac/36.2.343
- Robin F, Aggoune-Khinache N, Delmas J, Naim M, Bonnet R. Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob Agents Chemother 2010;54:466-470. https://doi.org/10.1128/AAC.00017-09
- Shiroto K, Ishii Y, Kimura S, et al. Metallo-beta-lactamase IMP-1 in Providencia rettgeri from two different hospitals in Japan. J Med Microbiol 2005;54(Pt 11):1065-1070. https://doi.org/10.1099/jmm.0.46194-0
- Zavascki AP, Carvalhaes CG, da Silva GL, et al. Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit. Infect Control Hosp Epidemiol 2012;33:627-630. https://doi.org/10.1086/665730
Cited by
- Clinical significance of Providencia bacteremia or bacteriuria vol.30, pp.2, 2015, https://doi.org/10.3904/kjim.2015.30.2.167
- A Lytic Providencia rettgeri Virus of Potential Therapeutic Value Is a Deep-Branching Member of the T5virus Genus vol.83, pp.23, 2015, https://doi.org/10.1128/aem.01567-17
- Detection of Acinetobacter spp. in Blood Cultures by an Improved Fluorescent in Situ Hybridization Assay vol.67, pp.1, 2015, https://doi.org/10.5604/01.3001.0011.6137
- Successful treatment of Providencia rettgeri cholecystitis and neutrophilic cholangitis in a cat vol.4, pp.1, 2015, https://doi.org/10.1177/2055116917750763
- Genomic analysis of a multidrug‐resistant clinical Providencia rettgeri (PR002) strain with the novel integron ln 1483 and an A/C plasmid replicon vol.1462, pp.1, 2020, https://doi.org/10.1111/nyas.14237
- Genome-based characterization of two Colombian clinical Providencia rettgeri isolates co-harboring NDM-1, VIM-2, and other β-lactamases vol.20, pp.1, 2015, https://doi.org/10.1186/s12866-020-02030-z
- Targeting Biofilm of MDR Providencia stuartii by Phages Using a Catheter Model vol.10, pp.4, 2015, https://doi.org/10.3390/antibiotics10040375
- Current antibiotic resistance patterns of rare uropathogens: survey from Central European Urology Department 2011-2019 vol.21, pp.1, 2015, https://doi.org/10.1186/s12894-021-00821-8